Delivery Order 36F79720D0227-36C24226N0564
- Veterans Integrated Service Network 19 issued a $2,426,314.08 delivery order to Exelan Pharmaceuticals Inc. on May 18, 2026, for the supply of Lenalidomide under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The GSA Federal Supply Schedule FSS-61-IB establishes a pre-competed framework for pharmaceutical procurement across federal agencies. Place of performance is Boca Raton, FL. The order is firm fixed price with an ultimate completion date of May 17, 2027. No set-aside was...
- The Department of Veterans Affairs, through Veterans Integrated Service Network 10, awarded a $2.55 million firm-fixed-price delivery order to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide, an oncology medication used in the treatment of hematologic malignancies. The contract, awarded on February 1, 2026, with an ultimate completion date of July 31, 2026, carries no set-aside designation and will be performed at Exelan's facility in Boca Raton, Florida. This delivery order is issued...
- The Department of Veterans Affairs, Veterans Integrated Service Network 23, awarded a delivery order contract to Exelan Pharmaceuticals Inc. for the supply of generic lenalidomide drug. This firm fixed-price delivery order, valued at $3.4M, was awarded on January 1, 2026, with an ultimate completion date of December 31, 2026. The contract will be performed in Boca Raton, Florida, and represents a non-competitive award with no set-aside designation. This delivery order falls under the GSA...
- This delivery order, awarded February 6, 2026, by Veterans Integrated Service Network 17, provides for the supply of Lenalidomide oral medication to support the Department of Veterans Affairs healthcare system. Exelan Pharmaceuticals Inc., a Boca Raton, Florida-based pharmaceutical manufacturer and distributor specializing in generic and branded drug products for federal agencies, was selected as the prime contractor. The award carries a ceiling value of $899,347.26 under a firm fixed-price...
- Exelan Pharmaceuticals Inc., a Boca Raton, Florida-based pharmaceutical manufacturing and distribution company, was awarded a $3.01 million delivery order by Veterans Integrated Service Network 6 on January 15, 2026, for the supply of Lenalidomide to the Asheville Veterans Affairs Medical Center. This firm-fixed-price delivery order, with an ultimate completion date of January 14, 2027, is issued under the parent Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a delivery order contract valued at $193,101.16 to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide 20mg to support emergency pharmacy operations. The award, issued on November 13, 2025, is structured as a firm fixed-price delivery order with performance completion targeted for September 30, 2026. Exelan Pharmaceuticals will deliver the medication to a location in Boca Raton, Florida. This contract...
- On December 11, 2025, the Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a $39,663 firm fixed-price delivery order to Exelan Pharmaceuticals Inc. for emergency pharmaceutical supplies. The contract calls for the delivery of Lenalidomide 10mg tablets (21 count) and Lenalidomide 15mg bottles, with two orders each of the specified National Drug Codes (76282-0698-48 and 76282-0699-47). The work is to be performed in Boca Raton, Florida, with an ultimate completion...
- Exelan Pharmaceuticals Inc., a pharmaceutical manufacturer and distributor based in Boca Raton, Florida, was awarded a delivery order for Lenalidomide by the Department of Veterans Affairs (VA), Veterans Integrated Service Network 21, on October 20, 2025. The contract is structured as a firm fixed-price delivery order with a ceiling value of $25,835.18 and an ultimate completion date of November 3, 2025. The award was made without a set-aside designation, allowing Exelan to compete openly...
- The Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 awarded a delivery order contract to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide, a pharmaceutical product used in cancer treatment and immunotherapy applications. This firm fixed-price delivery order, awarded on September 23, 2025, carries a ceiling value of $19,746.09 and is scheduled for completion by October 23, 2025. The contract utilizes no set-aside designation, allowing Exelan to compete...
- Exelan Pharmaceuticals Inc. was awarded an emergency delivery order valued at $20,432.31 for Lenalidomide 15mg and 2.5mg pharmaceutical products on October 9, 2025, by the Veterans Integrated Service Network 21 (VISN 21), a civilian component of the Department of Veterans Affairs. This firm fixed-price delivery order, which carries an ultimate completion date of December 31, 2025, was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract encompasses...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- 36F79720D0227Federal Supply Schedule
- 36F79720D0227-36C24226N0564Delivery Order
The Department of Veterans Affairs, Veterans Integrated Service Network 2, issued a $16.46 million delivery order to Exelan Pharmaceuticals Inc. on June 1, 2026, for Lenalidomide supply under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The FSS-61-IB is a GSA-administered Federal Supply Schedule for pharmaceutical products serving federal healthcare systems including the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. Place of performance is Boca Raton, FL. The order carries a firm fixed price structure with an ultimate completion date of May 31, 2029, and no set-aside designation. Exelan Pharmaceuticals, a for-profit pharmaceutical manufacturer and distributor headquartered in Boca Raton, specializes in production, distribution, and repackaging of generic and branded pharmaceuticals for federal healthcare systems. The company performs substantially all work at its Boca Raton facility.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5m | 5/28/26 |